TollB-001

N/A

Report date: 2026/05/22 20:01:29
NME

Base Information

Drug NameTollB-001
Drug Alias NameTollB-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 8 modulators
TargetsToll like receptor 8
Therapy Area/IndicationsScleroderma, SystemicArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesToll Biotech Co.Ltd.(Beijing)
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesToll Biotech Co.Ltd.(Beijing)
Inactive CompaniesN/A
Active IndicationsScleroderma, SystemicArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A